COMMUNIQUÉS West-GlobeNewswire

The Election Committee of Active Biotech AB proposes Michael Shalmi to be appointed new Chairman of the Board and Uli Hacksell to be appointed new member of the Board
02/05/2019
Active Biotech (NASDAQ, STOCKHOLM:ACTI) announce that the Election Committee of Active Biotech AB (publ) proposes that Michael Shalmi and Uli Hacksell are appointed new members of the Board of Directors and that Michael [...]
Matinas BioPharma to Ring NYSE Opening Bell® on May 6, 2019
02/05/2019
BEDMINSTER, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that it has been invited to ring the NYSE Opening Bell® [...]
Albireo to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast
02/05/2019
BOSTON, May 02, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that management will host a [...]
Progenics Pharmaceuticals Sets First Quarter 2019 Financial Results and Business Update Call for May 9
02/05/2019
NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, today [...]
InMode Announces Publication in Aesthetic Surgery Journal: The First Results of A New Combined Treatment for Skin Laxity
02/05/2019
InMode’s fractional technology and minimally invasive energy-based technology to address the “treatment gap” LAKE FOREST, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- InMode Ltd., a leading global provider of innovative, [...]
Caladrius Biosciences to Host 2019 First Quarter Financial Results Conference Call on Thursday, May 9, 2019 at 4:30 p.m. Eastern Time
02/05/2019
BASKING RIDGE, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the [...]
Novo Nordisk A/S: Share repurchase programme
02/05/2019
Bagsværd, Denmark, 2 May 2019 - On 1 February 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
XBiotech Announces Enrollment Completion, Positive Findings for Bermekimab in Pancreatic Cancer Study
02/05/2019
XBiotech and Cedars-Sinai Medical Center Evaluate Bermekimab in Combination with Chemotherapy in Patients with Pancreatic Cancer and Cachexia AUSTIN, Texas, May 02, 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) [...]
Tyme Technologies To Present at BioNJ's 9th Annual BioPartnering Conference on May 8th, 2019
02/05/2019
NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present a [...]
EDAP TMS SA to Announce First Quarter 2019 Financial Results on Wednesday, May 15, 2019
02/05/2019
Company to host conference call and webcast on Thursday, May 16, at 8:30 am EDT LYON, France, May 2, 2019 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release [...]
Mersana Therapeutics to Host Conference Call Announcing First Quarter 2019 Financial Results and Business Updates
02/05/2019
CAMBRIDGE, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
Neos Therapeutics to Host First Quarter 2019 Financial and Operating Results Conference Call on May 9th, 2019
02/05/2019
DALLAS and FORT WORTH, Texas, May 02, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) [...]
IntelGenx to Report First Quarter 2019 Financial Results on May 9, 2019 – Conference Call to Follow
02/05/2019
SAINT LAURENT, Quebec, May 02, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its first quarter 2019 financial results after market close on May [...]
MyoKardia to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019
02/05/2019
SOUTH SAN FRANCISCO, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of serious [...]
CytomX Therapeutics to Announce First Quarter 2019 Financial Results
02/05/2019
-Teleconference Scheduled for May 9, 2019, at 5:00 p.m. ET- SOUTH SAN FRANCISCO, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical [...]
Homology Medicines Presents Data from Gene Therapy and Gene Editing Programs and Manufacturing Capabilities at ASGCT Meeting
02/05/2019
- Homology’s Scalable HEK293 Suspension Manufacturing Process for AAVHSCs Demonstrated Superiority to a Baculovirus System and AAVHSC15 Showed Improved In Vivo Efficacy Compared to AAV5 in PKU Model - - Non-clinical [...]
CareDx Adds iBox Technology, Next Step Towards Artificial Intelligence in Transplant Care
02/05/2019
CareDx collaboration with Cibiltech provides prognostic information on allograft survival BRISBANE, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the [...]
Immunomedics to Report First Quarter 2019 Results and Host Conference Call and Webcast on May 9, 2019
02/05/2019
MORRIS PLAINS, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
Samumed Launches Phase 3 Lorecivivint (SM04690) Clinical Program in Knee Osteoarthritis
02/05/2019
Pivotal STRIDES trials to be conducted to support lorecivivint as a potential disease-modifying treatment for knee osteoarthritis First patient dosing is anticipated in the second quarter of 2019 SAN DIEGO, May 02, 2019 [...]

Pages